2ND ANNUAL SCHOOL OF NURSING ONCOLOGY OFFERS KEY TOPICS FOR BETTER PATIENT CARE
Sustained learning is much more important when you are now in the nursing clinical practice.
That’s why Physicians’ Education Resource (PER) ® will host the 2nd Annual School of Nursing Oncology™ providing the latest information on key oncology topics that can be precisely applied to nursing clinical practice in various settings.
“Continuing education is really important for helping nurses give the best care to patients,” meeting co-chair Beth Eaby-Sandy, MSN, CRNP, OCN, said in a video interview. “There are so many drugs, from so many different categories, that have so many different toxicities. And, you know, it’s really hard to keep up on all of the education.”
At the meeting, held from August 3 through 4 at the Loews Chicago O'Hare Hotel, faculty will confer strategies to help nurses optimize patient management and deliver beneficial insight in to the evolving treatment landscape.
As a thoracic oncology nurse practitioner at the Abramson Cancer Center, Hospital of the University of Pennsylvania in Philadelphia, Eaby-Sandy acclaimed how much treatments have changed in lung cancer over the years.
“When I think back 15 years ago, when I started as a nurse practitioner doing lung cancer, we truthfully had about 4 or 5 drugs that we used, that’s it. Everybody got paclitaxel and carboplatin,” she said. “I think that since I’ve been doing this, there has literally been 20 or 30 drugs that have been added to the arsenal. We didn’t even know about ALK mutations or EGFR mutations. So, there’s so much from just side effects, to the actual drugs, to what I’m actually looking for."
Aside from Eaby-Sandy, the event will also be co-chaired by Grace Cherry, RN, MSN, NP, oncology nurse practitioner at the UCLA Melanoma Program, and Laura S. Wood, RN, MSN, OCN, renal cancer research coordinator at the Cleveland Clinic Taussig Cancer Institute.
The meeting will include a mixture of didactic presentations, interactive discussion, and case-based learning opportunities—all described by PER® as “a dynamic experience, allowing participants to engage with faculty as they share their perspectives and personal experiences on clinical challenges commonly encountered in nursing practice.”
Nurses will have the opportunity to earn a maximum of 14 RN contact hours.
According to the program, at the conclusion of the meeting, participants should be better prepared to:
- Identify and manage treatment-related toxicities and adverse events across cancers.
- Appraise clinical data for state-of-the-art supportive care strategies.
- Interact with expert faculty and colleagues.
- Assimilate recent data into patient care.
- Advise patients and caregivers on what to expect with immunotherapies.
This activity is supported by educational grants from AstraZeneca, Celgene Corporation, and Helsinn Therapeutics (US) Inc.
Erudite Nursing Institute™ is in support with the said activity to gradually enhance nurses’ capacity and experience in the clinical setting. The institute believes that continued learning is the key to have more efficient and dynamic frontliners in the healthcare workforce.
Note: The foregoing article is copyrighted and may not be reproduced in part or entirety without advance written permission. For permissions or editorial corrections, contact: Ms. Kelsey Hanna, khanna@EruditeNursing.education